Overview

The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma

Status:
RECRUITING
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
This research is a prospective, multi-center, single-arm clinical trial aimed at assessing the standard pressurized intraperitoneal aerosol chemotherapy (PIPAC) utilizing a novel nebulized drug delivery system (NDDS) for patients with peritoneal metastatic adenocarcinoma (PMA) originating from gastric, colorectal, appendiceal, or ovarian cancer. The primary objectives of this study are to assess the safety and efficacy of PIPAC with the novel NDDS in the treatment of PMA. Primary endpoints include adverse events (AEs) and serious AEs, as assessed using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, incidences of device defects, postoperative pain scores evaluated using the Visual Analogue Scale / Score (VAS), and quality of life as measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30 scale, Version 3.0). Secondary endpoints include the intra-abdominal peritoneal cancer index (PCI), peritoneal regression grading score (PRGS), objective response rate (including partial response (PR) and complete response (CR)), improvement in ascites, conversion rate (patients proceeding to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) following initial PIPAC treatments), progression-free survival (PFS), and overall survival (OS).
Phase:
PHASE1
Details
Lead Sponsor:
Guangdong Provincial People's Hospital
Collaborators:
Affiliated Hospital of Qinghai University
Changzhi People's Hospital
First Hospital of China Medical University
Fujian Medical University Union Hospital
Henan Cancer Hospital
Jiangxi Provincial Cancer Hospital
Nanfang Hospital, Southern Medical University
Peking University Cancer Hospital & Institute
Ruijin Hospital
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Wenzhou Medical University
Shenzhen Second People's Hospital
Sixth Affiliated Hospital, Sun Yat-sen University
Southern Medical University, China
Sun Yat-sen University
The First Affiliated Hospital of Air Force Medicial University
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Tianjin Nankai Hospital
Tianjin Third Central Hospital
Tongji Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wannan Medical College Yijishan Hospital
West China Hospital
Xiangya Hospital of Central South University
Treatments:
Neoadjuvant Therapy